2m 2m 2m 2m 2m 2m 2m
PRELUDE THERAP (PRLD)
NASDAQ
$6.14-$0.49 (-7.33%)
Price as of Aug 24, 2026 9:52 AM EDT- $431.4MMarket Cap
- 434.68%1-Year Change
- BiotechnologyIndustry
PRELUDE THERAP (PRLD)
$6.14-$0.49 (-7.33%)
PRLD | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $6.63 | ||
Change | +$0.13 (+2.00%) | ||
Open | $6.56 | ||
High | $6.82 | ||
Low | $6.40 | ||
Previous Close | $6.50 | ||
Volume | 519,206 | ||
30-Day Average Volume | 507,587 | ||
1-Week Change | 19.46% | ||
1-Month Change | 64.11% | ||
1-Year Change | 434.68% | ||
3-Year Change | 98.50% | ||
5-Year Change | -78.61% | ||
Fundamentals | |||
Shares Outstanding | 65.1M | ||
Total Assets | $189.4M | ||
Market Cap | $431.4M | ||
Enterprise Value | $405.1M | ||
Period: QTR TTM FY | |||
Revenue | $5.7M | ||
Net Income | -$13.9M | ||
Free Cash Flow | -$15.6M | ||
EBIT | -$13.9M | ||
EBITDA | -$13.6M | ||
Net Working Capital | $116.9M | ||
EPS | -$0.14 | ||
Enterprise Value/EBITDA | -30 | ||
Enterprise Value/Revenue | 71 | ||
P/B | 3 | ||
P/E | -47 | ||
PEG | 6 | ||
Price/Free Cash Flow | -28 | ||
Price/Operating Cash Flow | -28 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue